Multiple coagulation factors and other plasma proteins

Multiple coagulation factors and other plasma proteins refers to a collective group of proteins found in the blood plasma that are essential for the maintenance of hemostasis and the regulation of the coagulation cascade. This group includes zymogens such as Prothrombin (Factor II), Factor VII, Factor IX, and Factor X, as well as regulatory proteins and enzymes involved in fibrinolysis and the complement system. In a pharmacological context, this term is often used to describe the collective targets of Vitamin K antagonists, which interfere with the gamma-carboxylation of several clotting factors, or to describe the components of therapeutic plasma-derived products like Prothrombin Complex Concentrates (PCC). Because these proteins function in a highly integrated cascade, drugs affecting this group often have broad effects on a patient's overall coagulation profile rather than targeting a single isolated receptor or enzyme. Clinical management of these targets requires careful monitoring of coagulation assays such as the International Normalized Ratio (INR) to balance the risk of hemorrhage against the risk of thrombosis.

Other names

Coagulation factorsPlasma proteinsClotting factorsVitamin K-dependent coagulation factors

Drugs interacting with this group typically act by inhibiting the synthesis of multiple factors (e.g., Vitamin K antagonists), replacing deficient factors (e.g., plasma concentrates), or inhibiting the proteolytic activity of multiple plasma proteases (e.g., antifibrinolytics).